Tomorrow Biostasis GmbH can fail. A serious century-scale system should assume that every operating company eventually changes, merges, restructures or disappears.
The important question is not whether bankruptcy is imaginable. It is which obligations sit inside the company when it happens.
For Tomorrow.bio, the answer differs sharply between a living member, an active case and a patient already transferred into long-term care.
Bankruptcy does not erase everything at once
Insolvency is a legal process for dealing with an entity that cannot meet its obligations. It is not a switch that instantly removes every employee, contract or piece of equipment.
An administrator may continue some operations, sell assets, transfer contracts or wind the company down. The result depends on law, finances and available counterparties.
No one can promise in advance which path a future insolvency would take.
What can be designed in advance is the boundary around assets that should not become ordinary company property.
Living members face the largest service gap
A living member still depends on the operating company for readiness, standby, transport and the procedure itself.
If Tomorrow.bio stopped operating before the member needed care, an insurance policy would still be an asset under its own terms.
But money cannot perform stabilization or perfusion. The member would need a successor arrangement or another provider willing and able to accept responsibility.
Terms, prices, geography and medical capabilities might differ. A replacement cannot be guaranteed decades in advance.
This is why members should keep contracts, funding records and medical instructions accessible through the system described in important documents to keep.
An active case is the hardest transition
Failure during standby or a procedure would create a more urgent problem than failure during ordinary operations.
Continuity then depends on deployed staff, equipment access, legal authority, local funeral coordination, payment and the ability to complete transport.
Organizational separation cannot remove that operational concentration. The procedure still needs a competent team in real time.
Redundant equipment, documented protocols and partner networks reduce the dependency on particular individuals, but they do not make the operating provider interchangeable overnight.
Stored patients are not company inventory
After transfer into long-term care, the architecture changes. Tomorrow.bio does not own the Rafz storage facility or hold the patient as an operating-company asset.
The Patient Care Foundation acts as legal guardian of the patient’s body and dedicated capital. EBF operates the facility under the patient-care arrangement.
Those roles are described in the Tomorrow.bio ecosystem and the public long-term storage agreement.
This separation is intended to keep stored patients and their care capital outside the ordinary creditor pool of the German operating company.
The defensible conclusion is that company bankruptcy alone should not cause immediate warming or release of stored patients.
That is not the same as saying nothing changes. Records, contracts, expertise and future procedural capacity may still need replacement.
PCF is designed to carry the obligation forward
PCF’s registered purpose prioritizes maintaining people already in biostasis. If the wider activity is threatened, preservation of neuronal structure receives explicit priority.
Its purpose also permits transfer of patients, responsibility, oversight and related funding to another suitable organization when that better fulfils patient care.
That successor authority is central to the bankruptcy design. A permanent mission should not require permanent dependence on one company or storage contractor.
Whether a suitable successor exists is still an empirical question. Authority to transfer is valuable, but it cannot manufacture capacity that does not exist.
EBF continues as a separate institution
EBF is a Swiss foundation with its own board, assets, facility, accounts and supervisory obligations.
Its statutes define a biostasis purpose independently of Tomorrow Biostasis GmbH. Dissolution assets must go to a Swiss tax-exempt organization with a similar purpose.
The facility’s passive liquid-nitrogen systems give operators time to respond to many ordinary disruptions without an immediate rise to damaging temperatures.
Storage still requires weekly replenishment, continuous level monitoring, nitrogen supply, maintenance and human intervention. The details appear in the classic storage system.
EBF therefore reduces dependence on the operating company. It does not eliminate dependence on competent institutional operation.
Follow three scenarios separately
Tomorrow.bio restructures but continues
A restructuring could preserve teams and contracts under a changed corporate form. Members might see administrative changes while procedures continue.
PCF and EBF would remain separate counterparties rather than assets automatically absorbed into that restructuring.
Tomorrow.bio winds down with time to transfer
Living-member files, funding instructions, equipment and staff relationships could potentially move to a successor, subject to contracts, privacy law and agreement.
Stored patients would remain under the patient-care and storage structures while procedural capacity is replaced.
Tomorrow.bio fails suddenly
Living members could face an immediate coverage gap. Stored patients would retain more structural protection because custody, capital and facility operation are elsewhere.
This is the scenario separation is mainly designed to improve. It narrows the failure rather than pretending the failure has no consequences.
The residual risks remain worth naming
Shared founders or directors can create correlated governance. A supplier crisis can affect multiple entities at once.
Patient capital can underperform. Storage costs can rise. Records can be incomplete, and law can change.
Those are not arguments that separation is useless. They explain why independent audit, public reporting, succession planning and operational redundancy still matter after legal separation.
The broader logic is developed in building organizations meant to last.
TL;DR: Tomorrow.bio bankruptcy would disrupt operations and living-member services, but stored patients and care funding are held separately. That separation reduces risk without guaranteeing permanent care.
How ready is your plan?
Use this short assessment to find practical gaps in your cryopreservation arrangements.
Loading the interactive tool...
Further reading